A Gouby

1.2k total citations
25 papers, 950 citations indexed

About

A Gouby is a scholar working on Epidemiology, Molecular Medicine and Molecular Biology. According to data from OpenAlex, A Gouby has authored 25 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Molecular Medicine and 7 papers in Molecular Biology. Recurrent topics in A Gouby's work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Mycobacterium research and diagnosis (4 papers). A Gouby is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Mycobacterium research and diagnosis (4 papers). A Gouby collaborates with scholars based in France, Tunisia and New Zealand. A Gouby's co-authors include N. Bouziges, M Ramuz, Gisèle Bourg, Pascale Fabbro-Péray, Albert Sotto, A Allardet-Servent, Corinne Merle De Boever, Jacques Jourdan, Danielle Sirot and Philippe Bouvet and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

A Gouby

24 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Gouby France 14 420 331 251 242 189 25 950
G. Chabanon France 19 408 1.0× 261 0.8× 244 1.0× 335 1.4× 130 0.7× 49 1.1k
E. Espaze France 15 477 1.1× 149 0.5× 227 0.9× 224 0.9× 170 0.9× 30 943
N. Bouziges France 19 662 1.6× 232 0.7× 258 1.0× 384 1.6× 213 1.1× 31 1.1k
F. Bert France 15 391 0.9× 262 0.8× 153 0.6× 222 0.9× 218 1.2× 27 930
Guilène Barnaud France 14 584 1.4× 244 0.7× 298 1.2× 277 1.1× 240 1.3× 23 1.1k
D. Sofianou Greece 16 616 1.5× 278 0.8× 160 0.6× 270 1.1× 228 1.2× 39 1.1k
Lisa Liolios Australia 8 627 1.5× 334 1.0× 164 0.7× 180 0.7× 142 0.8× 12 930
R. Vanhoof Belgium 21 561 1.3× 253 0.8× 254 1.0× 276 1.1× 491 2.6× 86 1.4k
K. Dornbusch Sweden 16 593 1.4× 305 0.9× 154 0.6× 177 0.7× 214 1.1× 47 1.1k
Fernando Garcı́a-Garrote Spain 18 515 1.2× 379 1.1× 207 0.8× 413 1.7× 306 1.6× 42 1.2k

Countries citing papers authored by A Gouby

Since Specialization
Citations

This map shows the geographic impact of A Gouby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Gouby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Gouby more than expected).

Fields of papers citing papers by A Gouby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Gouby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Gouby. The network helps show where A Gouby may publish in the future.

Co-authorship network of co-authors of A Gouby

This figure shows the co-authorship network connecting the top 25 collaborators of A Gouby. A scholar is included among the top collaborators of A Gouby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Gouby. A Gouby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bastide, Lionel, Sylvie Michaux‐Charachon, A Gouby, et al.. (2005). Novel synthetic molecules targeting the bacterial RNA polymerase assembly. Journal of Antimicrobial Chemotherapy. 57(2). 245–251. 43 indexed citations
2.
Defez, C., Pascale Fabbro-Péray, N. Bouziges, et al.. (2004). Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. Journal of Hospital Infection. 57(3). 209–216. 98 indexed citations
3.
Carrière, Christian, Sylvain Godreuil, A Gouby, et al.. (2004). Infections à Mycobacterium simiae : à propos de deux cas. Pathologie Biologie. 53(6). 324–327.
4.
5.
Joubert, P, et al.. (1999). A population approach to the forecasting of amikacin plasma and urinary levels using a prescribed dosage regimen. European Journal of Drug Metabolism and Pharmacokinetics. 24(1). 39–46. 13 indexed citations
6.
Bressolle, Françoise, A Gouby, Jean Martínez, et al.. (1996). Population pharmacokinetics of amikacin in critically ill patients. Antimicrobial Agents and Chemotherapy. 40(7). 1682–1689. 45 indexed citations
7.
Bressolle, Françoise, Fátima Gonçalves, A Gouby, & Marc Galtier. (1994). Pefloxacin Clinical Pharmacokinetics. Clinical Pharmacokinetics. 27(6). 418–446. 24 indexed citations
8.
Gouby, A, Catherine Neuwirth, Gisèle Bourg, et al.. (1994). Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. Journal of Clinical Microbiology. 32(2). 301–305. 115 indexed citations
9.
Costa, P., et al.. (1992). Disposition of roxithromycin in the epididymis after repeated oral administration. Journal of Antimicrobial Chemotherapy. 30(2). 197–201. 3 indexed citations
10.
Gouby, A, et al.. (1992). Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii. Journal of Clinical Microbiology. 30(6). 1588–1591. 103 indexed citations
11.
Gouby, A, et al.. (1992). DNA polymorphisms in methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. Journal of Clinical Microbiology. 30(8). 2092–2096. 54 indexed citations
12.
Branger, B., N. Bouziges, R Oulès, et al.. (1991). [A severe epidemic of Streptococcus group G infection in hemodialysis: epidemiologic survey by molecular biology and preventive measures].. PubMed. 12(5). 227–32. 2 indexed citations
13.
Bressolle, Françoise, et al.. (1991). Altered tobramycin pharmacokinetics during chemoprophylaxis in bladder surgery. Antimicrobial Agents and Chemotherapy. 35(7). 1454–1459. 1 indexed citations
14.
Gouby, A, B. Branger, R Oulès, & M Ramuz. (1988). Two cases of Mycobacterium haemophilum infection in a renal-dialysis unit. Journal of Medical Microbiology. 25(4). 299–300. 39 indexed citations
15.
Arich, C, et al.. (1987). [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].. PubMed. 35(5). 613–5. 6 indexed citations
16.
Gouby, A, et al.. (1987). [Septicopyemia caused by Fusobacterium gonidiaformans].. PubMed. 16(1). 34–34. 2 indexed citations
17.
Gouby, A, Gisèle Bourg, & M Ramuz. (1986). Previously undescribed 6.6-kilobase R plasmid in penicillinase-producing Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy. 29(6). 1095–1097. 26 indexed citations
18.
Branger, B., A Gouby, R Oulès, et al.. (1985). Mycobacterium haemophilum and mycobacterium xenopi associated infection in a renal transplant patient.. PubMed. 23(1). 46–9. 49 indexed citations
19.
Gouby, A, et al.. (1983). In vitro immunosuppressive activity of gram-positive (Streptococcus pyogenes) peptidoglycan on mouse lymphocytes. Immunobiology. 164(5). 343–348. 1 indexed citations
20.
Dubois, A., Claire Gervais, C Arich, et al.. (1982). [Liver diseases associated with Yersinia infections (author's transl)].. PubMed. 11(21). 1619–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Chabanon Breakdown of academic impact, for papers by E. Espaze Breakdown of academic impact, for papers by N. Bouziges Breakdown of academic impact, for papers by F. Bert Breakdown of academic impact, for papers by Guilène Barnaud Breakdown of academic impact, for papers by D. Sofianou Breakdown of academic impact, for papers by Lisa Liolios Breakdown of academic impact, for papers by R. Vanhoof Breakdown of academic impact, for papers by K. Dornbusch Breakdown of academic impact, for papers by Fernando Garcı́a-Garrote
Rankless by CCL
2026